It has been just about 3 weeks since a very important announcement was made by Starpharma - in regards to maximum tolerated dosage of anti-cancer drug Dep Docetaxel not being reached
The longer it takes to reach MTD (maximum tolerated dosage), the more valuable this anti-cancer drug being developed by Starpharma becomes. Not only that - all the collaborations with big pharmas on drug conjugates using dendrimers become "gold". Those companies will be wanting to sign a deal sooner rather than later with Starpharma to lock in - before any of the competitors do.
Exciting times coming
Above is my opinion and not investment advice
The longer it takes to reach maximum tolerated dosage of DEP DOCETAXEL, the more excited I become
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.2¢ |
Change
-0.001(1.08%) |
Mkt cap ! $38.39M | |||
| Open | High | Low | Value | Volume |
| 9.2¢ | 9.3¢ | 9.1¢ | $210.6K | 2.290M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 467139 | 9.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.4¢ | 152000 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |